The azole antifungal agent ketoconazole has been available since 1981 for the treatment of fungal infections. In 2013 the American Food and Drug Administration and the European Medicines Agency issued warnings or prohibitions against the clinical use of oral ketoconazole due to the risk of liver injury which may lead to liver transplantation or death.